The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression (Q34335586)

1 August 2017

The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression (English)

1 reference

1 August 2017

0 references

Philip Cowen

1

0 references

author name string

Ann C Sherwood

series ordinal

2

1 reference

PubMed ID

23535352

1 August 2017

language of work or name

English

0 references

publication date

27 March 2013

1 reference

Journal of Psychopharmacology

1 August 2017

1 reference

1 August 2017

27

1 reference

1 August 2017

7

1 reference

1 August 2017

575-583

1 reference

Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial

1 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Effect of low-dose acute tryptophan depletion on the specificity of autobiographical memory in healthy subjects with a family history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Acute citalopram administration may disrupt contextual information processing in healthy males

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Neurochemical modulation of response inhibition and probabilistic learning in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Lack of deleterious effects of buspirone on cognition in healthy male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

5-HT(6) receptor and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Serotonergic modulation of response inhibition and re-engagement? Results of a study in healthy human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

The effect of acute tryptophan depletion on the BOLD response during performance monitoring and response inhibition in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Antibiotics and growth factors in the management of fever and neutropenia in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Low-dose tryptophan depletion in recovered depressed women induces impairments in autobiographical memory specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Acute administration of citalopram facilitates memory consolidation in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Serotonin and human information processing: fluvoxamine can improve reaction time performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Cognitive deficits in the remitted state of unipolar depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Neuropsychological clustering highlights cognitive differences in young people presenting with depressive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recover

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Cognitive function and risk for depression in old age: a meta-analysis of published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Therapeutic potential of 5-HT2C receptor ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Abnormal prefrontal activity subserving attentional control of emotion in remitted depressed patients during a working memory task with emotional distracters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

The effect of Ondansetron on memory in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Neurocognitive impairment in adolescent major depressive disorder: state vs. trait illness markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

A functional magnetic resonance imaging study of verbal working memory in young people at increased familial risk of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Modulation of memory processes and cellular excitability in the dentate gyrus of freely moving rats by a 5-HT4 receptors partial agonist, and an antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Cognitive deficits are associated with functional impairment in severely depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

A meta-analysis of depression severity and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Effects of acute tryptophan depletion on memory, attention and executive functions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Quetiapine augmentation in depressed patients with partial response to antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Acquisition, retention, and recall of memory after injection of RS67333, a 5-HT(4) receptor agonist, into the nucleus basalis magnocellularis of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Serotonin and prefrontal cortex function: neurons, networks, and circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Drug development for Alzheimer's disease: where are we now and where are we headed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Working-memory fMRI reveals cingulate hyperactivation in euthymic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Effects of sertraline on autonomic and cognitive functions in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

The effects of acute treatment with tandospirone, diazepam, and placebo on driving performance and cognitive function in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Acute tryptophan depletion reduces activation in the right hippocampus during encoding in an episodic memory task

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

5-HT(3) receptors: role in disease and target of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Contrasting effects of systemic and intracerebral infusions of the 5-HT1A receptor agonist 8-OH-DPAT on spatial short-term working memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

Verbal memory performance during subchronic challenge with a selective serotonergic and a mixed action antidepressant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113482531

21 January 2018

Identifiers

DOI

10.1177/0269881113482531

1 reference

1 August 2017

1 reference

PubMed ID

23535352